Toxicology And Applied Pharmacology

Toxicology And Applied Pharmacology

毒理学与应用药理学

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Toxicology And Applied Pharmacology》是由Academic Press Inc.出版社于1959年创办的英文国际期刊(ISSN: 0041-008X,E-ISSN: 1096-0333),该期刊长期致力于毒理学领域的创新研究,主要研究方向为医学-毒理学。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.0503...%),以发表毒理学领域等方向的原创性研究为核心(研究类文章占比99.13%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在231篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Toxicology And Applied Pharmacology审稿周期约为 约1.0个月 约6周。该刊近年未被列入国际预警名单,年发文量约231篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 231 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
TOXICOLOGY 毒理学 PHARMACOLOGY & PHARMACY 药学
2区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学
2区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 118 / 354

66.8%

学科:TOXICOLOGY SCIE Q2 39 / 106

63.7%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 73 / 354

79.52%

学科:TOXICOLOGY SCIE Q1 17 / 106

84.43%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.8 SJR:0.788 SNIP:0.743
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Toxicology Q2 34 / 133

74%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q2 95 / 313

69%

期刊发文

  • Drug repurposing of ilepcimide that ameliorates experimental autoimmune encephalomyelitis via restricting inflammatory response and oxidative stress

    Author: Xu, Zhaomin; Lu, Sisi; Liu, Xi; Tang, Lu; Liu, Zehui; Cui, Jiayan; Wang, Wanyan; Lu, Weiqiang; Huang, Jin

    Journal: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2023; Vol. 458, Issue , pp. -. DOI: 10.1016/j.taap.2022.116328

  • Zinc finger protein 671 has a cancer-inhibiting function in colorectal carcinoma via the deactivation of Notch signaling

    Author: Wang, Yan; Chen, Fen-rong; Wei, Chong-cao; Sun, Lin-lang; Liu, Chen-yu; Yang, Long-bao; Guo, Xiao-yan

    Journal: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2023; Vol. 458, Issue , pp. -. DOI: 10.1016/j.taap.2022.116326

  • Fibroblast growth factor 2 (FGF2) ameliorates the coagulation abnormalities in sepsis

    Author: Sun, Yuanyuan; Ye, Fanrong; Li, Ding; Yang, Hongjing; Xu, Tingting; Zhong, Xincun; Lu, Yilun; Zhou, Hongmin; Pan, Jingye

    Journal: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2023; Vol. 460, Issue , pp. -. DOI: 10.1016/j.taap.2023.116364

  • Six first-line tyrosine kinase inhibitors reveal novel inhibition potential for the EGFR S768I mutation

    Author: Wang, Ying; Liu, Qian; Chu, Chunhong; Li, Lanxin; Wang, Zhenxing; Liu, Qiyu; Wu, Guangyao; Wei, Xiangkai; An, Lei; Ma, Jiguang

    Journal: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2023; Vol. 461, Issue , pp. -. DOI: 10.1016/j.taap.2023.116385

  • Advances in research strategies and approaches for toxicity testing of environmental exposures

    Author: Wang, Huihui; Zhang, Qiang; Pi, Jingbo

    Journal: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2023; Vol. 460, Issue , pp. -. DOI: 10.1016/j.taap.2023.116363

  • Assessment of the inhibition risk of chlorophenol substances on cytochrome P450 via cocktail inhibition assays

    Author: Zhang, Haoqian; Zhao, Furong; Liu, Yong; Li, Ying; Liu, Haiwen; Sun, Hongzhi

    Journal: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2023; Vol. 461, Issue , pp. -. DOI: 10.1016/j.taap.2023.116401

  • Ginsenoside 3?-O-Glc-DM (C3DM) suppressed glioma tumor growth by downregulating the EGFR/PI3K/AKT/mTOR signaling pathway and modulating the tumor microenvironment

    Author: Tang, Mei; Deng, Haidong; Zheng, Kailu; He, Jiuming; Yang, Jinling; Li, Yan

    Journal: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2023; Vol. 460, Issue , pp. -. DOI: 10.1016/j.taap.2023.116378

  • Targeted metabolomics analysis identified the role of FOXA1 in the change in glutamate-glutamine metabolic pattern of BaP malignantly transformed 16HBE cells

    Author: Xing, Yunkun; Liu, Zhiyu; Ma, Xue; Zhou, Chuan; Wang, Yu; Yao, Biyun; Fu, Juanling; Qi, Yanmin; Zhao, Peng

    Journal: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2023; Vol. 461, Issue , pp. -. DOI: 10.1016/j.taap.2023.116402